Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Pharmacotherapy Dosing Regimen in Cocaine and Opiate Dependent Individuals - 8
This study is currently recruiting participants.
Study NCT00218036 Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 16, 2005 Last Updated: April 7, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cocaine Abuse
Opiate Dependence
Additional conditions recognized in this trial
Cocaine-Related Disorders
Opioid-Related Disorders
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Substance-Related Disorders
Interventions listed in this trial
Modafinil 200mg
Modafinil 400mg
Citalopram 20mg
Citalopram 40mg
Placebo
Additional drug interventions recognized in this trial
Citalopram
Cocaine
Dexetimide
Modafinil
More general drug interventions related to this trial
Anesthetics
Anesthetics, Local
Anti-Dyskinesia Agents
Antidepressive Agents
Antidepressive Agents, Second-Generation
Antiparkinson Agents
Autonomic Agents
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Central Nervous System Stimulants
Cholinergic Agents
Cholinergic Antagonists
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Muscarinic Antagonists
Neuroprotective Agents
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Parasympatholytics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Psychotropic Drugs
Sensory System Agents
Serotonin Agents
Serotonin Uptake Inhibitors
Therapeutic Uses
Vasoconstrictor Agents
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
University of Texas
Back to top of Main Content
